Skip to main content
Investor Relations Contact Us Careers
Nasdaq: FEMY
Media

Femasys in the
conversation.

Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.

Couple reading Femasys content on a tablet
Featured

Recent News

All Recent News →

Podcasts

All Podcasts →
Podcast
Influential Women Podcast From Lab to Life the Journey Behind Solving Womens Healthcare
Apr 6, 2026 Listen ↗
Podcast
Clean Truths / Chemo Club Kathy Lee-Sepsick, Femasys CEO
Apr 3, 2026 Listen ↗

Webinars

All Webinars →
ON DEMAND
Innovations in Infertility, Featuring Dr. Bedient
May 15, 2026 Watch ↗
ON DEMAND
FemaSeed Webinar: An Introduction to FemaSeed & Clinical Trial Outcomes
Dec 5, 2024 Watch ↗

From the Blog

All From the Blog →
Blog
Intratubal insemination success, at age 39 – Aslyn’s story
Apr 6, 2026 Read →
Blog
FemaSeed FAQs → from cost to success rates, these are the questions being asked
Feb 10, 2026 Read →
Press Resources

Everything
journalists need.

Download official logos, executive headshots, product photography, and company fact sheets. For interview requests or additional materials, contact our media relations team directly.

Logo Package
SVG, PNG — light, dark, and color variants
Company Overview
One-page fact sheet • Updated Q2 2026
Product Animations
Animations for FemaSeed, FemVue, FemBloc, and FemCerv
Kathy Lee-Sepsick
Biography and photo
Media Relations
1-877-336-2562
Investor Relations
1-877-336-2562

For urgent media inquiries or to arrange an executive interview, please include your outlet name, story angle, and publication deadline in your email.

Stay Current

Women’s health news, delivered.

Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.

You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.